Author: DrugCenter

Get the latest drug center stories delivered to your inbox daily.



National Safety Month: Preventing Prescription Drug Abuse

During National Safety Month, the staggering realities about prescription drug abuse in America often take center stage. With the nonmedical use of prescription drugs growing throughout the country, organizations are taking action to bring awareness about the risks of substance abuse and addiction.


Tarceva Settlement Totals $67 Million For False Claims

Manufactured to treat non-small cell lung cancer, Tarceva manufacturers exaggerated information about the drug’s uses. Some of the inflated lacked research and evidence. After a whistleblower lawsuit was filed, the case was further investigated. The total legal settlement of $67 million will rectify the manufacturer’s false claim allegations and kickbacks to physicians.


Antibiotic Label Updates Made After Decades

The antibiotic class fluoroquinolones were developed for serious infections; however, they’re frequently prescribed for less severe conditions as well. Now, after more than 30 years on the market, recent research suggests they can lead to dangerous health complications. As a result, drug labels are receiving updates to reflect the new safety information.


FDA Launches New Invokana Safety Review

Recent studies about the newer class of type 2 diabetes drug, Invokana, show an increased risk of leg, foot and toe amputations. The FDA has since warned individuals and doctors to carefully watch for any warning signs that may occur while taking the drug.